Join the Crohn’s & Colitis Foundation (formerly CCFA) and the American Gastroenterological Association (AGA) for the inaugural Crohn’s & Colitis Congress™, taking place January 18-20, 2018 in Las Vegas. Expand your knowledge, network with inflammatory bowel diseases (IBD) leaders across multiple disciplines and get inspired to improve care for patients with Crohn’s disease and ulcerative colitis.
The Crohn’s & Colitis Congress is the must-attend meeting for all IBD professionals, offering a bold, multidisciplinary, forward-thinking approach to learning in the IBD space. Health-care professionals and research investigators across all disciplines will engage in the mission to transform IBD care and advance research by learning together as one care team in a single-track meeting. Sessions will focus on multidisciplinary clinical, surgical and research approaches to the current realities and challenges in the disease space and will incorporate the latest basic, translational and clinical research to address clinical questions. Attendees will:
a powerful network and share solutions with thought-leaders in IBD.
CME and MOC points.
skills and patient outcomes.
best practices at every stage of the patient’s disease journey.
cutting-edge basic, translational and clinical research in the IBD space.
new technologies and products from IBD-related exhibitors.
together as one multi-disciplinary care team.
The organizing committee and faculty represent key disciplines involved in the comprehensive care of IBD patients, as well as the foremost minds in research. Invited faculty include leading GIs, research investigators, surgeons, pediatricians, nurse practitioners and physician assistants, IBD nurses, dietitians, mental health professionals, radiologists and pathologists.
Pre-Congress workshops, taking place January 18, are also available. Additional fees may apply. IBD-related abstracts will be accepted Aug. 15-Oct. 31. Abstracts will be considered for oral, quick shot presentations and poster presentations.
Take a critical step towards finding cures and improving the lives
of adults and children living with IBD.